Revenue

A massive, 98-foot custom inflatable park debuts at Big Cedar Lodge, signaling a new era of deeply branded, immersive entertainment in the resort industry.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

Fintech leader Questrade is launching Questbank, a new digital bank aiming to disrupt the market with modern tech and a focus on everyday banking.

Enlight Renewable Energy posts strong Q1 results, with underlying profits surging 76% despite a misleading net income dip, and reaffirms its 2026 outlook.

Archway Verdun was just crowned for its non-alcoholic creations, proving that Quebec's hospitality scene is embracing a mindful, inclusive future.

A new report reveals U.S. firms lead in security spending intent but lag in AI deployment, creating a dangerous gap between belief and reality.

A new geological report confirms gold potential at Treasure Canyon, but for a company with no revenue, the path to riches is paved with high risk.

A new report finds over 80% of Canada's foundational forage fish stocks are unhealthy, threatening marine life and a multi-billion-dollar ocean economy.

New research reveals CFO salaries are surging toward $4M, yet tenures are plummeting. A look at the high-risk, high-reward world of modern finance chiefs.

At XPONENTIAL 2026, oToBrite unveils new 3D cameras and a strategy to equip North America's growing fleet of outdoor autonomous vehicles.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

California's LBC Capital expands its $1B bridge lending platform nationwide, betting its conservative underwriting can capture a growing private credit market.

As enterprises deploy advanced AI, a new security market is set to explode from zero to $8B by 2030, forcing a rethink of how we protect intelligent systems.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

The new Spring 2026 platform moves beyond data storage, using AI to transform MedTech regulatory affairs into a strategic, high-speed execution engine.

Global agency IDX opens a Swiss office, a strategic move fueled by rising client demand for evidence-based, AI-powered marketing and PR strategies.

With private equity backing and a new CEO known for transformation, the Portuguese ACMI specialist is doubling its fleet to capture a volatile market.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

A new AI tool promises to turn complex financial contracts from a multi-hour headache into minutes of work, reducing risk and unlocking strategic value.

Amid record-breaking sales, Acker launches a major Singapore auction and retail platform, betting on a new generation of digitally savvy Asian collectors.